International Science Journal Retracts 107 ‘Fake’ Chinese Research Papers
A science journal has deemed over one hundred research papers from China to be “fabricated” and retracted all of them from publication.
International publisher Springer Nature found that 107 research papers submitted by Chinese authors had been “compromised” and must be removed from the records, Mashable reports.
The retracted articles were published by the company in the journal Tumor Biology from 2012 to 2016.
According to Springer Nature editorial director for cell biology and biochemistry Peter Butler, while the papers were submitted to names of real reviewers, the email addresses used were fabricated.
“We are retracting these published papers because the peer review process required for publication in our journals had been deliberately compromised by fabricated peer reviewer reports,” Springer Nature stated according to RetractionWatch.
An investigation revealed that the real reviewers listed in the articles have denied conducting peer reviews in any of them. A huge percentage of the questionable articles involved cancer research from authors who all hail from Chinese organizations.
Fakery in Chinese research is not new. Last year, it was found that over 80% of the data used in clinical trials of new pharmaceutical drugs in China have been “fabricated”. The government investigation found that the data failed to meet analysis requirements, were incomplete, or totally non-existent.
Support our Journalism with a Contribution
Many people might not know this, but despite our large and loyal following which we are immensely grateful for, NextShark is still a small bootstrapped startup that runs on no outside funding or loans.
Everything you see today is built on the backs of warriors who have sacrificed opportunities to help give Asians all over the world a bigger voice.
However, we still face many trials and tribulations in our industry, from figuring out the most sustainable business model for independent media companies to facing the current COVID-19 pandemic decimating advertising revenues across the board.
We hope you consider making a contribution so we can continue to provide you with quality content that informs, educates and inspires the Asian community.
Even a $1 contribution goes a long way. Thank you for everyone’s support. We love you all and can’t appreciate you guys enough.